Chemours (NYSE: CC) reported Q1 EPS of $0.63, $0.27 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.49 billion.

Outlook

Vergnano said: "Despite a soft first quarter, the underlying fundamentals across our business remain solid. We anticipate titanium dioxide markets will stabilize as we move into the second half of 2019, and believe that we are well positioned in all our markets headed into the spring. The management team at Chemours is fully committed to executing our strategies, including Ti-Pure™ Value Stabilization, accelerated adoption of Opteon™ refrigerants, and application development in Fluoropolymers. We believe that consistent execution, together with prudent capital allocation, is the key to unlocking shareholder value over time."

For earnings history and earnings-related data on Chemours (CC) click here.